Pfizer succeeds brand power through ‘Novasc V’
(Dailypharm)
Pfizer Korea launched ‘Novasc V,’ which is a combination drug of Amlodipine and Valsartan.
LG Life Sciences is accountable of supplying Novasc V to Pfizer Korea. But Novasc V is Novartis ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
